Page 48 - Read Online

Page 116 Zhang et al. Neuroimmunol Neuroinflammation 2020;7:109-19 I http://dx.doi.org/10.20517/2347-8659.2019.018

DECLARATIONS
Authors’ contributions
Conceived of the presented idea: Yang J
Underwent literature review and synthesized a draft: Yang J, Zhang XJ, and Guo J
Contributed ideas throughout the process and approved the final draft: Yang J
Looked over and edited draft: Yang J, Zhang XJ, and Guo J

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Schirinzi T, Sancesario GM, Di Lazzaro G, D’Elia A, Imbriani P, et al. Cerebrospinal fluid biomarkers profile of idiopathic normal
pressure hydrocephalus. J Neural Transm (Vienna) 2018;125:673-9.
2. Manniche C, Hejl AM, Hasselbalch SG, Simonsen AH. Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus
versus Alzheimer’s disease and subcortical ischemic vascular disease: a systematic review. J Alzheimers Dis 2019;68:267-79.
3. Ghosh S, Lippa C. Diagnosis and prognosis in idiopathic normal pressure hydrocephalus. Am J Alzheimers Dis Other Demen
2014;29:583-9.
4. Keong NC, Pena A, Price SJ, Czosnyka M, Czosnyka Z, et al. Imaging normal pressure hydrocephalus: theories, techniques, and
challenges. Neurosurg Focus 2016;41:E11.
5. Savolainen S, Hurskainen H, Paljärvi L, Alafuzoff I, Vapalahti M. Five-year outcome of normal pressure hydrocephalus with or without a
shunt: predictive value of the clinical signs, neuropsychological evaluation and infusion test. Acta Neurochir (Wien) 2002;144:515-23.
6. Pomeraniec IJ, Bond AE, Lopes MB, Jane JA Sr. Concurrent Alzheimer’s pathology in patients with clinical normal pressure
hydrocephalus: correlation of high-volume lumbar puncture results, cortical brain biopsies, and outcomes. J Neurosurg 2016;124:382-8.
7. Graff-Radford NR. Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus. Neurology 2014;83:1573-5.
8. Pomeraniec IJ, Taylor DG, Bond AE, Lopes MB. Concurrent Alzheimer’s pathology in patients with clinical normal pressure
hydrocephalus. J Neurosurg Sci 2018.
9. McGovern RA, Nelp TB, Kelly KM, Chan AK, Mazzoni P, et al. Predicting cognitive improvement in normal pressure hydrocephalus
patients using preoperative neuropsychological testing and cerebrospinal fluid biomarkers. Neurosurgery 2019;85:E662-9.
10. Tarnaris A, Watkins LD, Kitchen ND. Biomarkers in chronic adult hydrocephalus. Cerebrospinal Fluid Res 2006;3:11.
11. Agren-Wilsson A, Lekman A, Sjöberg W, Rosengren L, Blennow K, et al. CSF biomarkers in the evaluation of idiopathic normal pressure
hydrocephalus. Acta Neurol Scand 2007;116:333-9.
12. Saito M, Nishio Y, Kanno S, Uchiyama M, Hayashi A, et al. Cognitive profile of idiopathic normal pressure hydrocephalus. Dement
Geriatr Cogn Dis Extra 2011;1:202-11.
13. Espay AJ, Da Prat GA, Dwivedi AK, Rodriguez-Porcel F, Vaughan JE, et al. Deconstructing normal pressure hydrocephalus:
ventriculomegaly as early sign of neurodegeneration. Ann Neurol 2017;82:503-13.
14. Nassar BR, Lippa CF. Idiopathic normal pressure hydrocephalus: a review for general practitioners. Gerontol Geriatr Med
2016;2:2333721416643702.
15. Reeves BC, Karimy JK, Kundishora AJ, Mestre H, Cerci HM, et al. Glymphatic system impairment in Alzheimer’s disease and idiopathic